|
 |
|
2016 Poland Tumor Marker Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Test Volume and Sales Forecasts, Competitive Strategies, Opportunities
This new report from VPGMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years....
|
 |
|
$4850.00 |
| |
|
|
|
2016 Portugal Tumor Marker Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Test Volume and Sales Forecasts, Competitive Strategies, Opportunities
This new report from VPGMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years....
|
|
|
$4850.00 |
| |
|
|
|
2016 Romania Tumor Marker Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stain--Test Volume and Sales Forecasts, Competitive Strategies, Opportunities
This new report from VPGMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years....
|
|
|
$4850.00 |
| |
|
|
|
2016 Slovakia Tumor Marker Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Test Volume and Sales Forecasts, Competitive Strategies, Opportunities
This new report from VPGMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years....
|
|
|
$4850.00 |
| |
|
|
|
2016 Slovenia Tumor Marker Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Test Volume and Sales Forecasts, Competitive Strategies, Opportunities
This new report from VPGMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years....
|
|
|
$4850.00 |
| |
|
|
|
2016 Sweden Tumor Marker Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Test Volume and Sales Forecasts, Competitive Strategies, Opportunities
This new report from VPGMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years....
|
|
|
$4850.00 |
| |
|
|
|
2016 Switzerland Tumor Marker Diagnostics Market: Emerging Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Test Volume and Sales Forecasts, Competitive Strategies, Opportunities
This new report from VPGMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years....
|
|
|
$4850.00 |
| |
|
|
|
2014 Analysis of the French Hospital Tumor Marker Testing Market
This new report from Venture Planning Group contains 533 pages, 43 tables, and presents a comprehensive analysis of the French hospital tumor marker testing market, including:
|
|
|
$3850.00 |
| |
|
|
|
2014 Analysis of the German Hospital Tumor Marker Testing Market
This new report from Venture Planning Group contains 530 pages, 40 tables, and presents a comprehensive analysis of the German hospital tumor marker testing market, including:
|
|
|
$3850.00 |
| |
|
|
|
2014 Analysis of the Italian Hospital Tumor Marker Testing Market
This new report from Venture Planning Group contains 525 pages, 38 tables, and presents a comprehensive analysis of the Italian hospital tumor marker testing market, including:
|
|
|
$3850.00 |
| |
|
|
|
2014 Analysis of the Spanish Hospital Tumor Marker Testing Market
This new report from Venture Planning Group contains 521 pages, 41 tables, and presents a comprehensive analysis of the Spanish hospital tumor marker testing market, including:
|
|
|
$3850.00 |
| |
|
|
|
2014 Analysis of the UK Hospital Tumor Marker Testing Market
This new report from Venture Planning Group contains 527 pages, 37 tables, and presents a comprehensive analysis of the UK hospital tumor marker testing market, including:
|
|
|
$3850.00 |
| |
|
|
|
2014 Opportunities in the French Hospital Tumor Marker
Testing Market
This new report from Venture Planning Group contains 533 pages, 43 tables, and presents a comprehensive analysis of the French hospital tumor marker testing market, including:
|
|
|
$3850.00 |
| |
|
|
|
2014 Opportunities in the German Hospital Tumor Marker
Testing Market
This new report from Venture Planning Group contains 530 pages, 40 tables, and presents a comprehensive analysis of the German hospital tumor marker testing market, including:
|
|
|
$3850.00 |
| |
|
|
|
2014 Opportunities in the Italian Hospital Tumor Marker
Testing Market
This new report from Venture Planning Group contains 525 pages, 38 tables, and presents a comprehensive analysis of the Italian hospital tumor marker testing market, including:
|
|
|
$3850.00 |
| |
|
|
|
2014 Opportunities in the Spanish Hospital Tumor Marker
Testing Market
This new report from Venture Planning Group contains 521 pages, 41 tables, and presents a comprehensive analysis of the Spanish hospital tumor marker testing market, including:
|
|
|
$3850.00 |
| |
|
|
|
2014 Opportunities in the UK Hospital Tumor Marker
Testing Market
This new report from Venture Planning Group contains 527 pages, 37 tables, and presents a comprehensive analysis of the UK hospital tumor marker testing market, including:
|
|
|
$3850.00 |
| |
|
|
|
2015 Spanish Hospital Tumor Marker Testing Market
This new report from VPGMarketResearch.com contains 521 pages, 41 tables, and presents a comprehensive analysis of the Spanish hospital tumor marker testing market, including:
|
|
|
$3850.00 |
| |
|
|
|
|